Stock AURORA CANNABIS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Aurora Cannabis Inc Stock Other OTC

Equities

CA05156X1087

Pharmaceuticals

Financials

Sales 2025 * 313M 229M Sales 2026 * 353M 258M Capitalization 411M 300M
Net income 2025 * -16M -11.68M Net income 2026 * - 0 EV / Sales 2025 * 1.31 x
Net cash position 2025 * - 0 Net cash position 2026 * - 0 EV / Sales 2026 * 1.16 x
P/E ratio 2025 *
-21.1 x
P/E ratio 2026 *
-251 x
Employees -
Yield 2025 *
-
Yield 2026 *
-
Free-Float 99.99%
More Fundamentals * Assessed data

Chart Aurora Cannabis Inc

Dynamic Chart

Latest news about Aurora Cannabis Inc

Aurora Cannabis Down 7.2% as it Trims Its Fiscal Q4 Loss MT
Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats DJ
Transcript : Aurora Cannabis Inc., 2024 Earnings Call, Jun 20, 2024
Aurora Cannabis Trims Q4 Net Loss MT
Aurora Cannabis Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Aurora Cannabis Brief: Re-Affirming Target of Reaching Positive Free Cash Flow by December 31, 2024 MT
Aurora Cannabis Brief: Says Q4 Represents Sixth Consecutive Quarter of Positive Adjusted EBITDA; Adds Ended Fiscal Year with a Cash Position of Near $180 Million with Cannabis Business Debt-Free MT
Aurora Cannabis Brief: Q4 Revenues $67.4 million Vs Forecast As Per Capital IQ of $69.54 Million and Last Year $64.03 Million MT
Aurora Cannabis Introduces Resin Cartridges in Australia MT
Aurora Cannabis Brief: Unveiling Premium Resin Cartridges in Australia MT
US Government Reclassifies Marijuana to Less-Restrictive Category MT
Justice Department Set to Post Cannabis Reclassification Plans MT
Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors CI
Aurora Cannabis Inc. Marks First Shipment of Medical Cannabis to the New Zealand Market CI
Aurora Cannabis Brief: Up 0.3% In US Premarket As Marks First Shipment of Medical Cannabis to the New Zealand Market MT
More news

Latest transcript on Aurora Cannabis Inc

Logo Aurora Cannabis Inc
Aurora Cannabis Inc., 2024 Earnings Call, Jun 20, 2024
More transcripts

Analyst Recommendations on Aurora Cannabis Inc

Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law MT
Canaccord Genuity Upgrades Aurora Cannabis to Buy From Hold MT
CIBC Adjusts Aurora Cannabis Price Target to CA$1 From CA$1.75, Maintains Neutral Rating MT
Aurora Cannabis Price Target Lowered to $1 at CIBC MT
Aurora Cannabis Brief: For Q1 2024, Expects Adjusted Gross Margins to be consistent with fiscal Q3 2023 and expects to maintain stated objective of a quarterly SG&A expense run rate below $30 million MT
More recommendations

Press releases Aurora Cannabis Inc

Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter PR
AURORA CANNABIS : Form 6-K PU
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market AQ
AURORA CANNABIS : NOTICE OF CHANGE OF AUDITOR - Form 6-K PU
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products AQ
More press releases

News in other languages on Aurora Cannabis Inc

Cannabis: Die Branche schwebt wieder auf Wolke sieben
Cannabis: El sector vuelve a dispararse
Cannabis : le secteur plane à nouveau
UN-Drogenkontrollrat warnt Deutschland vor Cannabis-Legalisierung
Aktien von Cannabis-Anbieter Cantourage heben bei Debüt ab
More news

Managers and Directors - Aurora Cannabis Inc

Managers TitleAgeSince
Miguel Martin CEO
 Chief Executive Officer 52 20-07-05
Simona King DFI
 Director of Finance/CFO 52 Feb. 20
Dave Aird CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Ronald Funk CHM
 Chairman 67 18-07-24
Rajesh Uttamchandani BRD
 Director/Board Member - May. 14
Michael Singer BRD
 Director/Board Member 60 16-05-19
More insiders

Company Profile

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Sector
Pharmaceuticals
Calendar
2024-08-07 - Q1 2025 Earnings Release (Projected)
More about the company

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+33.13% 5.82B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-31.17% 3.65B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-0.30% 3.13B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-23.56% 2.68B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.11% 2.31B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+40.27% 1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+40.53% 1.45B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-25.53% 1.36B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-12.05% 1.44B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. ACB Stock
  4. Stock